Nova Leap Health Corp. (TSXV:NLH)
Canada · Delayed Price · Currency is CAD 0.4350
-0.0050 (-1.14%)
Jul 31, 2026, 12:58 PM EST
Nova Leap Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 32.23 | 31.47 | 25.76 | 26.18 | 28.21 | 21.28 | |
Revenue Growth | 21.95% | 22.15% | -1.60% | -7.18% | 32.55% | 22.93% |
Cost of Revenue | 19.38 | 18.98 | 15.87 | 16.41 | 18.23 | 14.07 |
Gross Profit | 12.85 | 12.48 | 9.89 | 9.77 | 9.98 | 7.21 |
Selling, General & Admin | 10.63 | 10.44 | 8.33 | 8.29 | 9.32 | 7.21 |
Depreciation & Amortization Expenses | 0.79 | 0.83 | 0.58 | 0.89 | 1.36 | 0.86 |
Other Operating Expenses | 0.11 | 0.11 | 0.11 | 0.13 | 0.36 | 0.37 |
Total Operating Expenses | 11.53 | 11.38 | 9.02 | 9.31 | 11.04 | 8.44 |
Operating Income | -1.32 | -1.11 | -0.86 | -0.46 | 1.06 | 1.23 |
Interest Expense | -0.35 | -0.35 | -0.11 | -0.14 | -0.27 | -0.4 |
Other Non-Operating Income (Expense) | -0.58 | -0.89 | 1.06 | -1.68 | 0.13 | 4.11 |
Total Non-Operating Income (Expense) | -0.92 | -1.24 | 0.95 | -1.83 | -0.14 | 3.7 |
Pretax Income | 0.4 | -0.13 | 1.81 | -1.37 | -1.21 | 2.47 |
Provision for Income Taxes | 0.29 | 0.26 | 0.23 | -0.09 | -0.51 | -0.32 |
Net Income | 0.21 | -0.19 | 1.38 | -1.05 | -0.84 | 1.76 |
Net Income to Common | 0.21 | -0.19 | 1.38 | -1.05 | -0.84 | 1.76 |
Net Income Growth | -74.25% | - | - | - | - | 40.15% |
Shares Outstanding (Basic) | 87 | 87 | 86 | 86 | 81 | 74 |
Shares Outstanding (Diluted) | 87 | 87 | 87 | 86 | 81 | 78 |
Shares Change | 0.10% | 0.60% | 0.68% | 5.83% | 4.90% | 16.89% |
EPS (Basic) | 0.00 | -0.00 | 0.02 | -0.01 | -0.01 | 0.02 |
EPS (Diluted) | 0.00 | -0.00 | 0.02 | -0.01 | -0.01 | 0.02 |
EPS Growth | -70.00% | - | - | - | - | 0% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1.76 | 1.56 | 1.36 | 2.13 | 0.95 | 2.18 |
Free Cash Flow Growth | 45.06% | 14.19% | -35.91% | 123.97% | -56.44% | -27.47% |
Free Cash Flow Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 |
Gross Margin | 39.87% | 39.67% | 38.38% | 37.31% | 35.37% | 33.89% |
Operating Margin | -4.10% | -3.51% | -3.35% | -1.76% | 3.77% | 5.79% |
Profit Margin | 0.66% | -0.60% | 5.35% | -4.03% | -2.96% | 8.27% |
FCF Margin | 5.45% | 4.95% | 5.29% | 8.12% | 3.37% | 10.24% |
EBITDA | -0.54 | -0.27 | -0.28 | 0.42 | 2.42 | 2.09 |
EBITDA Margin | -1.67% | -0.87% | -1.09% | 1.62% | 8.57% | 9.84% |
EBIT | -1.32 | -1.11 | -0.86 | -0.46 | 1.06 | 1.23 |
EBIT Margin | -4.10% | -3.51% | -3.35% | -1.76% | 3.77% | 5.79% |
Effective Tax Rate | 71.84% | -198.89% | 12.45% | 6.68% | 42.35% | -13.07% |